EuBiologics Co., Ltd. (KOSDAQ: A206650)
Health Care · Biotechnology · KR
₩8,660.00
-5.15% today · -31.4% 1Y
EuBiologics Co., Ltd. (KOSDAQ: A206650) operates in the Biotechnology industry within the Health Care sector. The company is valued at $229.65M.
Over the last twelve months the share price has lost 31.4%, trading between 6.95K and 17.70K.
Tweenvest scores EuBiologics Co., Ltd. across four factors: quality 69/100, value 54/100. Its strongest factor is quality.
A206650 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $229.65M
- Revenue (TTM)
- $65.01M
- P/E
- —
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- 0.16
- 52-week high
- ₩17,700.00
- 52-week low
- ₩6,950.00
- Avg volume (3M)
- —
- Shares outstanding
- 36.75M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $469.68B | $266.82 | +0.39% |
| Amgen Inc.NasdaqGS: AMGN | $239.09B | $445.50 | +0.74% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $184.47B | $148.77 | +1.38% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $140.13B | $552.00 | -0.15% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.24B | $832.63 | -0.11% |
| argenx SEENXTBR: ARGX | $64.17B | €898.00 | +2.14% |
| Moderna, Inc.NasdaqGS: MRNA | $63.41B | $158.31 | -0.33% |
| CSL LimitedASX: CSL | $59.49B | AU$173.64 | +2.68% |
Figures last refreshed Aug 18, 2026.